| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070066520 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 03/22/2007 | US20070066515 Novel glycoprotein and pharmaceutical composition containing the same |
| 03/22/2007 | US20070066440 Automatic transmission |
| 03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065488 Food composition having anti-stress action |
| 03/22/2007 | US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 03/22/2007 | US20070065451 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065435 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065434 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065431 A polynucleotide encoding a monomeric non-antibody ligand having a loop partly modified or replaced by or amino acid(s); improved solubility; medical diagnosis; targets of drugs, steroids, pesticides, antigens, growth factors, tumour markers, cell surface proteins or viral coat proteins |
| 03/22/2007 | US20070065380 provitamin C is prepared from Lycium fruit extract; decomposed in the body to produce vitamin C; improved stability in the body and prolonged life in the body; bioavailability; vitamin C-fortified food; apply to skin protecting from ultraviolet damage, wrinkles and aging |
| 03/22/2007 | US20070065377 Composition for promoting synthesis of collagen, and composition for external preparation for skin comprising the same |
| 03/22/2007 | US20070065371 Novel Dry Powder Inhalation System For Transpulmonary Administration |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622597A1 Histamine h3 agonist for use as therapeutic agent for lipid/glucose metabolic disorder |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/21/2007 | EP1764413A1 Protein preparation containing s1-5 |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764134A2 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 03/21/2007 | EP1764110A1 Compositions comprising an insulin sensitivity enhancer and a biguanide |
| 03/21/2007 | EP1764106A2 Use of insulin-like growth factor I for the inhibition of ischemic injury involving the liver |
| 03/21/2007 | EP1764103A2 Crystalline amifostine compositions and methods for the preparation and use of same |
| 03/21/2007 | EP1764096A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 03/21/2007 | EP1764095A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 03/21/2007 | EP1763361A2 Steroid sparing agents and their use |
| 03/21/2007 | EP1763350A1 Nicotinamide derivatives and their use as therapeutic agents |
| 03/21/2007 | EP1763345A2 Kinase inhibitors for treating cancers |
| 03/21/2007 | EP1763343A2 Calcium trifluoroacetate for preparing antiangiogenetic medicaments |
| 03/21/2007 | EP1517703B1 Placental growth factor as a target for the treatment of osteoporosis |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 03/21/2007 | EP1399113B1 Cosmetic or dermatological composition comprising n-acylaminoamide derivatives |
| 03/21/2007 | EP1303305B1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 03/21/2007 | EP1289529B1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | EP1112270B1 Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
| 03/21/2007 | EP0865446B1 Agents for promoting bone formation |
| 03/21/2007 | EP0805853B1 Lineage-directed induction of human mesenchymal stem cell differentiation |
| 03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
| 03/21/2007 | CN1934073A Novel crystal of triterpene derivative |
| 03/21/2007 | CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 03/21/2007 | CN1933846A Acerola leaf extract-containing blood sugar level increase inhibitor and age formation inhibitor, and food containing them |
| 03/21/2007 | CN1931875A High purity ulinastatin and its prepn process and medicine composition |
| 03/21/2007 | CN1931859A New fused imidazole derivative |
| 03/21/2007 | CN1931353A Curcuma extract and its prepn process, medicine composition and use |
| 03/21/2007 | CN1931336A Chinese medicine composition and its prepn process |
| 03/21/2007 | CN1931225A Use of flavescent sophora root in preparing medicine for preventing and treating angiostenosis |
| 03/21/2007 | CN1931224A Injection for treating thecal cyst |
| 03/21/2007 | CN1931202A Prepn process of setose abelmoschus prepn |
| 03/21/2007 | CN1931190A Toad skin extract and its medicine prepn and their prepn |
| 03/21/2007 | CN1305872C Process for producing quinazoline ditosylate salt compounds |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/21/2007 | CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 03/21/2007 | CN1305853C Process for the manufacture of HMG-coa reductase inhibitors |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305848C 2,3-dihydro-isoindol-1-ones with MAO-B inhibiting activity |
| 03/21/2007 | CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 03/21/2007 | CN1305838C Cinnamide derivatives |
| 03/21/2007 | CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries |
| 03/21/2007 | CN1305488C Ginseng and aconite preparation for treating qi vacuity and yang desertion and its preparation method |
| 03/21/2007 | CN1305475C Boronic ester and acid compounds, synthesis and uses |
| 03/21/2007 | CN1305474C Nose cavity administering formulation of nalmefene |
| 03/21/2007 | CN1305465C Cell growth regulating factor I and its preparation process |
| 03/21/2007 | CN1305464C Temperature-reducing refreshing aerosol |
| 03/21/2007 | CN1305463C Ginseng and aconite spraying agent for treating qi vacuity and yang desertion and its preparation method |
| 03/21/2007 | CN1305403C Preparation method of lichee oral liquid containing intelligence beneficial component |
| 03/20/2007 | US7193108 Phenylpropionic acid derivatives |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192969 Ester derivatives |
| 03/20/2007 | US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 03/20/2007 | US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192960 Sodium channel blockers |
| 03/20/2007 | US7192956 Inducing contraception by delivering to a female of child-bearing age a selective estrogen receptor modulator comprising cyclothiocarbamate derivative |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192950 Psychological disorders; eating disorders; dietetics |
| 03/20/2007 | US7192949 Anticarcinogenic and antiproliferative agents |
| 03/20/2007 | US7192946 Hyperlipemia agents; bile acid transport inhibitors |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | US7192940 Ether compounds |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192924 Corticotropin releasing factor 2 receptor agonists |
| 03/20/2007 | US7192923 For therapy and prophylaxis of muscular dystrophy |
| 03/20/2007 | US7192733 screening for drugs that inhibit prostaglandin endoperoxidase (PGE) synthase, for use in treatment of inflammation, arthritis, cancer, Alzheimer's disease, in modulating apoptosis, and treating pain |
| 03/20/2007 | US7192617 camu camu seed extract as an active component, wherein the whitening agent does not comprise camu camu pulp extract |
| 03/20/2007 | US7192616 Slow down or even inhibit cellular differentiation and/or proliferation. |
| 03/20/2007 | US7192611 Administering a Free-B-Ring flavonoid as cyclooxygenase-2 (COX-2) inhibitor to treat osteoarthritis, rheumatoid arthritis, menstrual cramps, Systemic Lupus Erythromatosis, psoriasis, migraines, inflammatory bowel disease, cancer |
| 03/20/2007 | US7192576 neurotrophic activity; expression vector; facilitates proliferation, differentiation and/or survival of a cell |
| 03/20/2007 | US7192570 Compositions of somatostatin analogues |